Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Celluvisc 1.0% w/v Eye drops, solution, unit dose
Medicines register · Ireland

Celluvisc 1.0% w/v Eye drops, solution, unit dose

Authorisation PPA1463/147/001 · IMED Healthcare Ltd.,

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 18 Nov 2026
Licence holder
IMED Healthcare Ltd., (all products →)
Active substance
Carmellose sodium
Dosage form
Eye drops, solution
Route of administration
Ocular use
ATC code
S01XA20
First authorised
28/08/2009
Prescription status
Product not subject to medical prescription
Supply
Supply through pharmacies only
Legal basis
Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC

Carmellose sodium: supply and approvals

4 authorised products on the HPRA list contain Carmellose sodium. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 17 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 17 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 17 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

Parallel import (PPA). A parallel product authorisation: the HPRA allows this product to be imported from another EU or EEA country and sold in Ireland. It has been authorised for 17 years (since 28 August 2009). The HPRA list does not say whether it is on sale.

Other medicines with Carmellose sodium in Ireland

3 other products on the HPRA list contain Carmellose sodium, from 2 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Celluvisc 0.5 % w/v eye drops solution, unit doseAbbVie LimitedNational authorisation (PA)Marketed
Celluvisc 1% w/v Eye drops, solution, unit doseAbbVie LimitedNational authorisation (PA)Marketed
Celluvisc 1.0% w/v eye drops, solution, unit dosePCO Manufacturing Ltd.Parallel import (PPA)Not stated

The licence holder

IMED Healthcare Ltd., holds 178 products on the HPRA list, with 119 different active substances; 1 of the products is marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 18 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.